HSIC Henry Schein Inc

Worldwide Market Reports has published a new research study on the Cross Country Healthcare Personnel Placement Service Market, predicting substantial growth in the coming years. The report provides a comprehensive analysis of the market landscape, including dynamics, drivers, restraints, and growth opportunities, covering various segments like Travel Nursing and Temporary Staffing. It also offers regional insights, competitive analysis of key players like AMN Healthcare and Cross Country Healthcare, and details on research methodology.

Henry Schein (Nasdaq: HSIC) plans to select a new CEO by mid-January 2026 to replace Stanley Bergman, who will retire after 45 years with the company. The selection process follows a significant private equity investment from KKR earlier in 2025 aimed at strategic growth. This transition comes as Henry Schein has made new partnerships and initiatives, including with Amazon Web Services and a share repurchase program.

Henry Schein announced it will present at J.P. Morgan's Healthcare Investor Conference on January 13, 2026, in San Francisco. The presentation will be webcast live and replays will be available on their website. Henry Schein, Inc. (Nasdaq: HSIC) provides solutions for healthcare professionals globally.

Zuckerman Investment Group significantly increased its stake in Henry Schein (HSIC) by purchasing 72,040 additional shares, totaling an investment of approximately $3.38 million. This move comes as Henry Schein reported strong third-quarter results, with revenue up 5% to $3.3 billion and adjusted EBITDA rising. The company also announced a new $200 million efficiency plan and substantial share buybacks, making it an attractive long-term investment despite underperforming the broader market.

Henry Schein, Inc., a leading provider of healthcare solutions, announced it will present at the J.P. Morgan Healthcare Investor Conference on Tuesday, January 13, 2026, at 4:30 p.m. PST. The Company, a Fortune 500 company and S&P 500® index member, serves over 1 million global customers with more than 300 valued solutions. Its sales reached $12.6 billion in 2022, growing at an approximate compound annual rate of 11.2% since becoming a public company in 1995.

Henry Schein, Inc. announced its participation in the J.P. Morgan Healthcare Investor Conference on January 13, 2026. The company's presentation will be live-streamed at 3:00 p.m. PST / 6:00 p.m. EST, and replays will be available on their website. Henry Schein, a global provider of healthcare solutions, achieved sales of $12.7 billion in 2024 and serves over 1 million customers worldwide.